Maravai LifeSciences Holdings, Inc.
MRVI
$4.15
-$0.14-3.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 35.74% | 9.72% | 46.20% | -43.36% | -24.17% |
| Total Depreciation and Amortization | 0.89% | 6.34% | 8.94% | 8.25% | 12.39% |
| Total Amortization of Deferred Charges | -44.67% | -58.81% | -51.43% | -39.19% | -26.92% |
| Total Other Non-Cash Items | -76.69% | -81.44% | -95.50% | 10.67% | 16.92% |
| Change in Net Operating Assets | -648.68% | 36.72% | 385.51% | -123.32% | -81.35% |
| Cash from Operations | -704.07% | -871.24% | -265.40% | -168.42% | -79.98% |
| Capital Expenditure | 56.65% | 58.14% | 60.23% | 54.40% | 55.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 98.06% | -- | -- | -- | -17,189.91% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -100.00% | -88.97% | -93.89% | -38.90% |
| Cash from Investing | 70.57% | -29.15% | -5.99% | -3.62% | 23.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 76.41% | 97.76% | -3,782.80% | -3,805.43% | -3,858.90% |
| Issuance of Common Stock | 219.73% | 219.73% | -- | 378.53% | 122.89% |
| Repurchase of Common Stock | -- | -- | -- | 98.95% | 97.37% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -125.23% | -1,111.07% | -305.93% | -206.90% | 79.56% |
| Cash from Financing | 72.16% | 93.00% | -26,591.24% | -26,355.59% | -465.61% |
| Foreign Exchange rate Adjustments | -202.74% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 56.94% | 58.22% | -23,006.56% | -4,229.25% | -315.48% |